Varenicline
Description
Varenicline is a type of Nicotinic Cholinergic Receptor Partial Agonist Pharmaceutical Drug. Specifically, Varenicline is a partial agonist at the a partial agonist of the alpha-4, beta-2 Nicotinic Cholinergic Receptor.
Varenicline may Counteract these Toxic Substances
Recreational Drugs
Varenicline may reduce the craving for Alcohol. [1]
Varenicline may reduce the craving for Nicotine in Tobacco smokers. [2]
Varenicline binds with high affinity and selectivity to alpha-4, beta-2 Nicotinic Cholinergic Receptors to produce an effect sufficient to alleviate symptoms of craving and withdrawal (agonist activity), while simultaneously resulting in blockade of the rewarding and reinforcing effects of smoking by preventing nicotine binding to alpha-4, beta-2 Nicotinic Receptors (antagonist activity).
You have read 34% of this topic
Keep reading Varenicline
- Toxic Effects of Varenicline
- Nervous System
- Bioavailability
- Dosage Recommendations
- Commercial Availability of Varenicline
- Oral Products
- Every cited reference behind this topic
- All 5,000+ interlinked topics, search and notes
No credit card needed to start a trial. Already a member? Log in